效应性调节性T细胞浸润预测弥漫大B细胞淋巴瘤(非特指型)不良预后
研究对82例淋巴结弥漫大B细胞淋巴瘤(非特指型)患者淋巴结采用FOXP3与CTLA-4双免疫染色,评估真正调节性T细胞(效应性Treg)浸润与预后的关系。FOXP3阳性细胞高浸润与总生存显著较好相关(P = .0233);而FOXP3/CTLA-4双阳性细胞高浸润与总生存(P = .0121)和无进展生存(P = .0171)显著较差相关,且独立于国际预后指数。
要点
- FOXP3阳性细胞高浸润与DLBCL, NOS患者总生存较好显著相关(P = .0233)。
- FOXP3/CTLA-4双阳性细胞高浸润与总生存(P = .0121)和无进展生存(P = .0171)较差显著相关。
- FOXP3/CTLA-4双阳性细胞(效应性Treg)在DLBCL, NOS进展中起重要作用。
核心结论
- FOXP3/CTLA-4双阳性细胞即效应性Treg在DLBCL, NOS进展中起重要作用。
- FOXP3阳性细胞高浸润与总生存较好显著相关(P = .0233),而FOXP3/CTLA-4双阳性细胞高浸润与总生存(P = .0121)和无进展生存(P = .0171)较差显著相关,且独立于国际预后指数。
研究设计与样本
- 研究对82例淋巴结DLBCL, NOS患者的淋巴结组织采用抗FOXP3和抗CTLA-4抗体进行双免疫染色。
主要发现
- FOXP3阳性细胞高浸润患者的总生存显著优于FOXP3阳性细胞低水平患者(P = .0233)。
- FOXP3/CTLA-4双阳性细胞高浸润患者的总生存显著差于FOXP3/CTLA-4双阳性细胞低水平患者(P = .0121)。
- FOXP3/CTLA-4双阳性细胞高浸润患者的无进展生存显著差于FOXP3/CTLA-4双阳性细胞低水平患者(P = .0171)。
- FOXP3/CTLA-4双阳性细胞高浸润与不良预后的关联独立于国际预后指数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Regulatory T cells (Tregs) specifically express the transcription factor forkhead box P3 (FOXP3) and contribute to tumor progression. FOXP3-positive cells have been recently proven to be heterogeneous in phenotype and function, including effector Tregs (eTregs), naïve Tregs, and non-Tregs, which harbor no suppressive function. Therefore, it is crucial to investigate the "true Treg (eTreg)" population, rather than the entire FOXP3 population, with regards to their effect on tumor immunity. In particular, in diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), FOXP3-positive cells correlated with a better prognosis. The present study sought to evaluate the relationship between the prognosis of DLBCL, NOS patients and the infiltration of true Tregs by employing dual immunostaining with FOXP3 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is a negative immunomodulatory known to be expressed by eTregs, but not by non-Tregs. Lymph nodes from 82 nodal DLBCL, NOS patients were stained with anti-FOXP3 and anti-CTLA-4 antibodies. A high infiltration of FOXP3-positive cells was associated with a significantly better prognosis than patients with low levels of FOXP3-positive cells for overall survival (OS) (P = .0233). In sharp contrast, a high infiltration of FOXP3/CTLA-4 double-positive cells was significantly associated with a poor prognosis than patients with low levels of FOXP3/CTLA-4 double-positive cells for OS (P = .0121) and progression-free survival (P = .0171), independent of the international prognostic index. FOXP3/CTLA-4 double-positive cells, eTregs, play an important role in DLBCL, NOS progression.
引用
- Nakayama S, Yokote T, Akioka T, et al. Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified. Blood Adv. 2017. PMID: 29296965. doi:10.1182/bloodadvances.2016000885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。